General Electric to Sell Biopharma Business to Danaher for US$21.4 B
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 3 (Table of Contents)
Published: 13 Mar-2019
DOI: 10.3833/pdr.v2019.i3.2412 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its largest deal to date, Danaher has agreed to buy General Electric’s (GE) biopharmaceutical business, GE Biopharma, for US$21...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS